Oxford researchers, supported by the Medical Research Council, are developing personalized cancer vaccines using AI, leveraging one of the UK's most powerful supercomputers, Dawn.

Oxford researchers, supported by the Medical Research Council, are developing personalized cancer vaccines using AI, leveraging one of the UK's most powerful supercomputers, Dawn.

A vaccine designed with the help of artificial intelligence has entered human trials in what scientists are calling a world-first moment for medical research and drug development.